Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and

Jingwei Lu1, Reeva Aggarwal, Suman Kanji

  • 1Cardiovascular Medicine, The Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America.

Plos One
|September 22, 2011
PubMed
Abstract

Insights

Human Vγ2Vδ2 T cells limit ovarian tumor cell proliferation by downregulating apoptosis and cell cycle molecules. Tumor cells resist by upregulating pErk1/2, decreasing MICA, but Erk1/2 inhibition restores MICA and T cell-mediated lysis.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • The mechanisms of human Vγ2Vδ2 T cell-mediated tumor immunity are not fully understood.
  • NKG2D-MICA interactions play a role in tumor cell recognition by Vγ2Vδ2 T cells.

Purpose of the Study:

  • To elucidate the mechanisms by which Vγ2Vδ2 T cells inhibit ovarian tumor cell proliferation.
  • To investigate the role of pErk1/2 and MICA in Vγ2Vδ2 T cell-mediated tumor immune evasion.

Main Methods:

  • MTT assay
  • Propidium Iodide (PI)-BrdU co-staining
  • Western blot analysis
  • Use of Erk1/2 inhibitor

Main Results:

  • Vγ2Vδ2 T cells limit ovarian tumor cell proliferation by downregulating apoptosis and cell cycle-related molecules.
  • Ovarian tumor cells resist Vγ2Vδ2 T cell recognition by upregulating pErk1/2, which decreases surface MICA levels.
  • Erk1/2 inhibition restores MICA levels and sensitizes resistant tumor cells to Vγ2Vδ2 T cell-mediated lysis by upregulating cell cycle and apoptosis-related molecules.

Conclusions:

  • Vγ2Vδ2 T cells exert novel inhibitory effects on ovarian tumor cells.
  • Targeting the Erk1/2 pathway can overcome tumor immune evasion and enhance Vγ2Vδ2 T cell immunotherapy for ovarian cancer.